The invention provides tetrahydroquinoline and related compounds, pharmaceutical compositions, methods of inhibiting RORγ activity, reducing the amount of IL-17 in a subject, and treating immune disorders and inflammatory disorders using such tetrahydroquinoline and related compounds are provided.
本发明提供
四氢喹啉及相关化合物、制药组合物、抑制RORγ活性的方法、减少受试者体内I
L-17的数量以及使用该
四氢喹啉及相关化合物治疗免疫性疾病和炎症性疾病的方法。